SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
31434I just finished reviewing the 10Q for info on the auditor situation. there is nSPSEIFERT-8/6/2004
31433Speaking of disgruntled investors, some LGND investors may get a second bite at Henry Niman-8/5/2004
314321st ALbany: Ligand Pharmaceuticals (LGND - $ 13.58) Neutral Lowering Rating omopgcw-8/4/2004
31431Well, I couldn't resist and bought some as well. May turn out to be a long-FiloF-8/4/2004
31430I figured there would be a rally at the open today..but then a sell-off because Arthur Radley-8/4/2004
31429Kinda funny (not in a Ha!Ha! way)... we are heading near the level at which I boFiloF-8/4/2004
31428And you seriously believe that??Michael Young-8/4/2004
31427>>No way was it a fee issue.<< DeGeeter added the company indicatedLabrador-8/4/2004
31426No way was it a fee issue. If that was the case the transition would have been Michael Young-8/4/2004
31425Looks like my $12 downside target was too optimistic. Recent news suggests LGNDMichael Young-8/4/2004
31424By the way, if the concern was really over the auditor's fees, I am sure thaLabrador-8/4/2004
31423>>DeGeeter added the company indicated it dismissed Deloitte & Touche Labrador-8/4/2004
31422SP, That comment came from an analyst being quoted in a CBSMarketWatch report...Arthur Radley-8/4/2004
31421I listened to the call and don't recall them saying D and T was too expensivSPSEIFERT-8/4/2004
31420If this debacle with the accounting firm leaving weeks ago and no announcement uArthur Radley-8/3/2004
31419Nice call! Somewhat lower guidance despite upbeat rhetoric is tanking the stocktuck-8/3/2004
31418Ligand Reports Financial Results for Second Quarter 2004: Net Product Sales Incrmopgcw-8/3/2004
31417Oppy on ppar delay/stock holding up well: After the close Thursday, Ligand Phamopgcw-7/9/2004
31416Bad news tonight...stock will take a hit tomorrow!!! 2 year delay in Lilly deal.Arthur Radley-7/8/2004
31415Drug tested at OHSU prevents MS-like disease in animals Medication could treat, mopgcw-6/20/2004
31414Ligand Earns $1.0 Million Milestone Payment as GlaxoSmithKline Advances Developmnigel bates-6/14/2004
31413Just two problems I have with it are: 1. Self-promoting your results with whankeokalani'nui-6/8/2004
31412The market was decidedly unexcited about this news. Why?Harold Engstrom-6/7/2004
31411Ligand and Investigators Present Exciting Scientific and Clinical Data Updates fmopgcw-6/7/2004
31410A new thread for disgruntled biotech investors Subject 54984Edscharp-6/4/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News